The Causes of Snoring and What Actually Works: An Evidence-Based Guide (2026)

What causes snoring (and why it matters for treatment)

The causes of snoring fall into three anatomical categories, each requiring a different intervention. The most common cause is soft palate and uvula vibration, which occurs when airway muscle tone decreases during sleep and allows the soft tissues at the back of the throat to flutter during breathing. ¹ The second cause is tongue-base collapse, where the tongue falls backward and partially obstructs the airway, creating turbulent airflow and vibration. The third cause is nasal passage narrowing from congestion, structural deviation, or inflammation, which forces mouth breathing and increases negative pressure in the throat during inhalation.

Most anti-snoring products target only one of these three mechanisms. Mandibular advancement devices pull the jaw and tongue forward to prevent tongue-base collapse and reduce soft palate vibration. Nasal dilators widen the nasal passages to reduce nasal resistance. Throat sprays claim to lubricate soft tissues to reduce vibration, but this mechanism lacks clinical support. ¹

Understanding which cause applies to you determines which product will work. If you snore equally whether your nose is clear or congested, the cause is likely soft palate or tongue obstruction, not nasal narrowing. If you snore only when lying on your back, the cause may be position-dependent tongue collapse. If you snore more during allergy season or when you have a cold, nasal obstruction may be a contributing factor. Most people have more than one contributing cause, which is why combination approaches (weight loss plus a mandibular advancement device, for example) often work better than single interventions.

When the causes of snoring require medical attention

Snoring is not always benign. Obstructive sleep apnea (OSA) is a condition where the airway repeatedly closes completely during sleep, causing breathing pauses (apneas) that fragment sleep and reduce oxygen levels. ¹ OSA is associated with cardiovascular disease, stroke, and daytime impairment. The distinction between primary snoring (annoying but not dangerous) and OSA (a treatable medical condition) requires clinical evaluation, not self-diagnosis.

See a physician if you have any of the following: witnessed breathing pauses during sleep, gasping or choking episodes that wake you, severe daytime sleepiness despite adequate time in bed, morning headaches, difficulty concentrating, or high blood pressure that is difficult to control. A sleep study (polysomnography) is the diagnostic standard for OSA. ¹ Moderate to severe OSA typically requires CPAP therapy or other physician-supervised interventions. The over-the-counter products we review here are appropriate for primary snoring and mild OSA, but they are not substitutes for medical evaluation when warning signs are present.

Age, obesity, alcohol use, and anatomical factors (large neck circumference, small jaw, enlarged tonsils) all increase OSA risk. ¹ If you are overweight, losing 10% of your body weight can significantly reduce apnea severity. ¹⁰ If you drink alcohol in the evening, stopping or reducing intake often improves snoring because alcohol relaxes airway muscles. These lifestyle changes are worth trying before or alongside any product intervention.

The three we recommend

These three products address specific causes of snoring with strong or moderate clinical evidence. None is a universal solution. Match the mechanism to your cause.

SnoreRX: strongest evidence for soft palate and tongue-base snoring

Mandibular advancement devices (MADs) are the most clinically validated over-the-counter intervention for snoring. They work by holding the lower jaw in a forward position during sleep, which pulls the tongue forward and tightens the soft tissues at the back of the throat. This prevents tongue collapse and reduces soft palate vibration. ²

A 2024 meta-analysis of randomized controlled trials found MADs effective for reducing apnea-hypopnea index (AHI) across mild, moderate, and severe OSA. ² A 2024 study in the Journal of the American College of Cardiology compared MADs to CPAP for cardiovascular outcomes and found comparable blood pressure reductions in patients with mild to moderate OSA. ⁴ A 2023 trial comparing MADs to CPAP for symptom outcomes (daytime sleepiness, fatigue, mood, attention, quality of life) found no clinically significant difference between the two therapies in patients with mild OSA. ⁵ A 2023 systematic review found long-term efficacy of MADs was sustained over multiple years of use. ³

SnoreRX is our pick in this category because it offers calibrated micro-adjustment in 1mm increments, allowing you to fine-tune jaw advancement for effectiveness and comfort. It uses a boil-and-bite molding system for a custom fit to your teeth. The device is cleared by the FDA as a Class II medical device.

Side effects are honest and worth knowing before purchase. A 2025 systematic review of MAD side effects found the most common complaints were jaw discomfort (especially during the first two weeks), excessive salivation, dry mouth, and temporary tooth tenderness. ⁶ Long-term use can cause minor tooth movement or bite changes in some users, though serious dental complications are rare when the device is properly fitted. ⁶ Most users adapt within two to four weeks. If jaw pain persists beyond that period, consult a dentist before continuing use.

SnoreRX will not help if nasal obstruction is your primary cause. It addresses tongue and soft palate mechanisms only.

ZQuiet: softer alternative with the same mechanism

ZQuiet is a pre-formed mandibular advancement device with a hinged design that allows limited jaw movement during sleep. It uses the same forward-jaw mechanism as SnoreRX and is supported by the same body of clinical evidence for MADs generally. ^{2 4 5}

The trade-off is less precise adjustment. ZQuiet comes in two sizes (original and narrow) but does not offer the 1mm calibration increments that SnoreRX provides. Some users find the soft plastic and hinge more comfortable for initial adaptation, while others prefer the rigidity and adjustability of a custom-molded device. ZQuiet is $10 cheaper than SnoreRX and may be a reasonable choice if you want to try the MAD mechanism before committing to a fully adjustable model.

Side effects are similar to other MADs: jaw discomfort, salivation changes, and potential tooth movement with long-term use. ⁶ The same cautions apply. Do not use a MAD if you have advanced periodontal disease, loose teeth, or active temporomandibular joint (TMJ) disorder without consulting a dentist first.

Hale Breathing: only for congestion-related snoring

Hale Breathing is a nasal airway opener that fits inside the nostrils to widen the nasal passages and improve airflow. Nasal dilators work by reducing nasal resistance, which decreases the negative pressure generated during inhalation and reduces the collapsing force on the throat. ⁸

The critical limitation is specificity. A 2019 randomized controlled trial tested a nasal dilator strip (a similar mechanism to Hale Breathing’s internal dilator) in adults with chronic nocturnal nasal congestion and found objective improvements in sleep quality and subjective improvements in nasal breathing. ⁸ However, the authors noted that nasal dilators have limited efficacy for primary snoring when nasal obstruction is not the dominant cause. ⁸ If your snoring persists when your nose is completely clear, or if you can breathe easily through your nose while awake, a nasal dilator will not address the problem.

Hale Breathing is appropriate if: (1) you cannot breathe comfortably through your nose while lying down, (2) your snoring worsens during allergy season or when you have a cold, or (3) you have been told by a physician that you have a deviated septum or chronic nasal congestion. It is not appropriate if your snoring occurs regardless of nasal congestion, because in that case the cause is soft palate or tongue obstruction, which a nasal dilator cannot address.

Hale Breathing is the lowest-cost option we recommend ($29.99) and has minimal side effects. Some users report initial discomfort from the insertion or mild nasal irritation, but serious adverse events are rare. The device is reusable and should be cleaned daily.

Do not expect a nasal dilator to fix snoring caused by soft palate vibration or tongue collapse. This is the most common misconception in the category, fueled by marketing that overstates the breadth of effectiveness. The evidence is clear: nasal dilators work when nasal obstruction is the problem. ⁸ They do not work when it is not.

Skip these

We recommend against three products in this category, two because they do not address snoring mechanisms and one because it lacks clinical support despite being a top seller.

SnoreStop: weak evidence for throat lubricants

SnoreStop is an oral spray marketed as an anti-snoring solution. The proposed mechanism is lubrication of the soft palate and throat tissues to reduce vibration during breathing. We found no randomized controlled trials supporting this mechanism in peer-reviewed journals. A search of PubMed and Cochrane databases for trials on throat lubricants or oral sprays for snoring returned no relevant results with positive findings.

User reviews on retail platforms report minimal to no effect, with satisfaction scores significantly lower than for mandibular advancement devices or nasal dilators. SnoreStop is a top-selling product, likely due to low cost and ease of use (a spray requires no fitting or adaptation period). But ease of use does not compensate for lack of efficacy. We cannot recommend a product without clinical evidence, regardless of sales volume.

If soft tissue vibration is your problem, a mandibular advancement device addresses the anatomical cause by repositioning the jaw and tongue. A throat spray does not.

Better Breathing Sport: not designed for snoring

Better Breathing Sport is a breathing trainer that uses resistance to strengthen the diaphragm and respiratory muscles. It is marketed primarily for athletic performance and respiratory endurance. It does not address the anatomical causes of snoring (soft palate vibration, tongue collapse, nasal obstruction) and should not be purchased for that purpose.

The product may have value for its intended use, but it is not relevant to this guide. Some third-party retailers incorrectly position breathing trainers as snoring solutions. They are not. Training your respiratory muscles does not prevent your tongue from collapsing backward or your soft palate from vibrating during sleep.

AirPhysio: for mucus clearance, not snoring

AirPhysio is an oscillating positive expiratory pressure (OPEP) device designed to help clear mucus from the lungs in people with chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, or other conditions causing excess mucus production. It has no relevance to snoring mechanisms.

Some marketing materials position OPEP devices as breathing aids for general use, which creates confusion. AirPhysio improves mucus clearance through oscillating airflow that loosens secretions. It does not widen nasal passages, reposition the jaw, or prevent soft tissue vibration. Do not buy AirPhysio to address snoring. It is not designed for that and will not work for that.

When lifestyle changes or CPAP are better options

Over-the-counter products are not the right solution for everyone. Four alternatives are worth considering depending on your specific situation.

Weight loss (for overweight individuals with OSA)

Obesity is the strongest modifiable risk factor for obstructive sleep apnea. A 2017 randomized trial found that lifestyle interventions producing weight loss significantly reduced apnea severity in obese individuals with type 2 diabetes. ¹⁰ A 2026 systematic review found psychological interventions supporting weight management improved OSA outcomes. ¹¹ If you are overweight and have been diagnosed with OSA, losing 10% to 15% of your body weight often produces measurable reductions in AHI and symptom severity.

Structured weight-loss programs with behavioral support cost $500 to $3,000 depending on duration and format (in-person vs. telehealth). The investment is worth it if you are motivated and able to sustain the program. Weight loss also reduces cardiovascular risk, which is a major concern in untreated OSA.

Weight loss is not a substitute for CPAP or MAD therapy during the weight-loss period. Most physicians recommend continuing treatment while pursuing weight loss, then reassessing with a follow-up sleep study once target weight is achieved.

Positional therapy (for back-sleeping snorers)

If your snoring occurs only when you sleep on your back, the cause is likely position-dependent tongue or soft palate collapse. A 2025 meta-analysis found positional therapy (interventions that keep you off your back during sleep) effective for position-dependent OSA. ⁹ Options include tennis-ball shirts (a shirt with a pocket sewn into the back containing a tennis ball or foam wedge that makes back-sleeping uncomfortable), positional alarms (wearable devices that vibrate when you roll onto your back), and specialized pillows designed to encourage side-sleeping.

Positional therapy costs $20 to $150 depending on the device. Effectiveness is limited to the subset of snorers whose obstruction is truly position-dependent. If you snore in all positions, positional therapy will not help. A bed partner can usually tell you whether your snoring is position-dependent by observing over several nights.

Positional therapy is well-tolerated and has no side effects, making it a reasonable first-line intervention if you know your snoring is back-position-specific.

Oropharyngeal exercises (for mild OSA or primary snoring)

Oropharyngeal exercises are structured tongue and soft palate muscle-training routines designed to increase muscle tone and reduce collapsibility during sleep. A 2020 Cochrane review found oropharyngeal exercises produced modest reductions in snoring frequency and OSA severity in adults. ¹² The exercises are based on protocols developed by speech therapists and include tongue presses, palate slides, and jaw movements performed for 10 to 15 minutes daily.

Exercises are free and can be done at home following published protocols or smartphone apps. The main limitation is compliance. Benefits appear after 8 to 12 weeks of consistent daily practice, and stopping the exercises often leads to relapse. ¹² If you are disciplined and prefer a non-device intervention, oropharyngeal exercises are a reasonable option for mild OSA or primary snoring. They are not effective for moderate to severe OSA or for snoring caused by nasal obstruction.

CPAP (for moderate to severe OSA)

Continuous positive airway pressure (CPAP) remains the gold standard for moderate to severe obstructive sleep apnea. A sleep study is required for diagnosis and prescription. CPAP works by delivering pressurized air through a mask to keep the airway open throughout the sleep cycle. It is highly effective at eliminating apneas and improving oxygen levels, cardiovascular outcomes, and daytime symptoms.

CPAP costs $500 to $3,000 for the device, plus ongoing costs for masks, filters, and tubing. Insurance typically covers CPAP for diagnosed OSA, though coverage varies. The main drawback is adherence. Many users find the mask uncomfortable, the noise disruptive, or the system inconvenient for travel. Adherence rates (defined as using the device at least 4 hours per night on 70% of nights) range from 40% to 70% depending on the study. ⁴

Multiple studies show mandibular advancement devices produce comparable outcomes to CPAP for mild to moderate OSA. ^{4 5} This makes MADs a reasonable first-line option before escalating to CPAP, particularly for people who travel frequently, have claustrophobia, or strongly prefer a non-mask solution. If a MAD does not adequately control symptoms or if your OSA is severe, CPAP should be the next step. Work with a sleep physician to determine the right intervention for your severity level and preferences.